Microneedle Drug Delivery Systems Market Size

Microneedle Drug Delivery Systems Market size was over USD 812.47 million in 2024 and is projected to reach USD 2030.5 million by 2037, growing at around 7.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of microneedle drug delivery systems is assessed at USD 859.92 million.. The market is estimated to grow on the back of the increasing prevalence of chronic conditions such as diabetes, cancer, heart disease, and stroke. Over the past ten years, there has also been an increase in other lifestyle-related illnesses such as Alzheimer's disease, chronic kidney disease, and chronic lung disease. According to the Centers for Disease Control and Prevention, four out of ten people in the US have two or more chronic diseases, and six out of ten adults in the country have at least one. Furthermore, according to statistics, in 2021, around 530 million adults aged 20-79 have been diagnosed with diabetes globally, a figure projected to rise to 640 million by 2030 and 780 million by the end of 2040.

Additionally, the non-invasive method of microneedle patch immunization has been thoroughly researched. The World Health Organization has ranked vaccine reluctance as one of the top ten hazards to global health. According to a recent study conducted in October 2020, 53.1% of the people under that study chose not to get vaccinated or were unsure if they should get vaccinated. Fear of needles, pain and side effects are the usual causes of vaccine reluctance. The market is anticipated to expand owing to the rising demand for microneedle patches that don't require needles or the effect of pain associated with it.